Literature DB >> 19351279

Molecular profiling to predict hepatocellular carcinoma outcome.

Yujin Hoshida, Augusto Villanueva, Josep M Llovet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19351279      PMCID： PMC3668659          DOI： 10.1586/egh.09.5

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN： 1747-4124            Impact factor:   3.869


× No keyword cloud information.
  21 in total

1.  Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma.

Authors:  Y J Chen; S H Yeh; J T Chen; C C Wu; M T Hsu; S F Tsai; P J Chen; C H Lin
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.

Authors:  Angelo Sangiovanni; Ersilio Del Ninno; Pierangelo Fasani; Cristina De Fazio; Guido Ronchi; Raffaella Romeo; Alberto Morabito; Roberto De Franchis; Massimo Colombo
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

3.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

Review 4.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

5.  Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Minekatsu Nishida; Yoshitaka Maeda; Naohide Mori; Takashi Takao; Takao Tamesa; Akira Tangoku; Hisahiro Tabuchi; Kenji Hamada; Hironobu Nakayama; Hideo Ishitsuka; Takanobu Miyamoto; Akira Hirabayashi; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

6.  Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.

Authors:  Qing-Hai Ye; Lun-Xiu Qin; Marshonna Forgues; Ping He; Jin Woo Kim; Amy C Peng; Richard Simon; Yan Li; Ana I Robles; Yidong Chen; Zeng-Chen Ma; Zhi-Quan Wu; Sheng-Long Ye; Yin-Kun Liu; Zhao-You Tang; Xin Wei Wang
Journal:  Nat Med       Date:  2003-03-17       Impact factor: 53.440

7.  Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis.

Authors:  Irene Oi-lin Ng; Xin-yuan Guan; Ronnie Tung-ping Poon; Sheung-Tat Fan; Joyce Man-Fong Lee
Journal:  J Pathol       Date:  2003-03       Impact factor: 7.996

8.  Hepatocellular carcinoma in Italian patients with cirrhosis.

Authors:  M Colombo; R de Franchis; E Del Ninno; A Sangiovanni; C De Fazio; M Tommasini; M F Donato; A Piva; V Di Carlo; N Dioguardi
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

9.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

Authors:  Ju-Seog Lee; In-Sun Chu; Jeonghoon Heo; Diego F Calvisi; Zongtang Sun; Tania Roskams; Anne Durnez; Anthony J Demetris; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

10.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Hiroshi Imamura; Yutaka Matsuyama; Eiji Tanaka; Takao Ohkubo; Kiyoshi Hasegawa; Shinichi Miyagawa; Yasuhiko Sugawara; Masami Minagawa; Tadatoshi Takayama; Seiji Kawasaki; Masatoshi Makuuchi
Journal:  J Hepatol       Date:  2003-02       Impact factor: 25.083
View more
  18 in total

1.  Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.

Authors:  Sonja K Olsen; Robert S Brown; Abby B Siegel
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

Review 2.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 3.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

4.  Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.

Authors:  D Heim; K Cornils; K Schulze; B Fehse; A W Lohse; T H Brümmendorf; H Wege
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

Review 5.  Sorafenib: where do we go from here?

Authors:  Abby B Siegel; Sonja K Olsen; Arthur Magun; Robert S Brown
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

6.  Mitochondrial reactive oxygen species and complex II levels are associated with the outcome of hepatocellular carcinoma.

Authors:  Jianhua Wu; Fei Zhao; Yufei Zhao; Zhanjun Guo
Journal:  Oncol Lett       Date:  2015-08-18       Impact factor: 2.967

7.  Prognostic gene signatures for hepatocellular carcinoma: what are we measuring?

Authors:  Kenneth K Tanabe; Yujin Hoshida
Journal:  Ann Surg Oncol       Date:  2013-11       Impact factor: 5.344

8.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

Authors:  Stephanie Roessler; Hu-Liang Jia; Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Ju-Seog Lee; Snorri S Thorgeirsson; Zhongtang Sun; Zhao-You Tang; Lun-Xiu Qin; Xin Wei Wang
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

9.  New strategies in hepatocellular carcinoma: genomic prognostic markers.

Authors:  Augusto Villanueva; Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Clara Alsinet; Radoslav Savic; Helena Cornella; Josep M Llovet
Journal:  Clin Cancer Res       Date:  2010-08-16       Impact factor: 12.531

10.  Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

Authors:  Anuradha Budhu; Stephanie Roessler; Xuelian Zhao; Zhipeng Yu; Marshonna Forgues; Junfang Ji; Edward Karoly; Lun-Xiu Qin; Qing-Hai Ye; Hu-Liang Jia; Jia Fan; Hui-Chuan Sun; Zhao-You Tang; Xin Wei Wang
Journal:  Gastroenterology       Date:  2013-01-31       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.